The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 21, 2007

Filed:

Sep. 19, 2001
Applicants:

Hiromasa Miyaji, Sunto-gun, JP;

Motoko Haruoka, Sunto-gun, JP;

Hiroyuki Nagata, Machida, JP;

Toshio Ota, Fujisawa, JP;

Ayako Kawabata, Sagamihara, JP;

Sumio Sugano, Suginami-ku, JP;

Yusuke Nakamura, Yokohama, JP;

Inventors:

Hiromasa Miyaji, Sunto-gun, JP;

Motoko Haruoka, Sunto-gun, JP;

Hiroyuki Nagata, Machida, JP;

Toshio Ota, Fujisawa, JP;

Ayako Kawabata, Sagamihara, JP;

Sumio Sugano, Suginami-ku, JP;

Yusuke Nakamura, Yokohama, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 9/20 (2006.01); C12N 1/20 (2006.01); C12Q 1/34 (2006.01); C12Q 1/68 (2006.01); C12P 21/06 (2006.01); A61K 38/46 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a novel phospholipase Apolypeptide, DNA encoding the polypeptide, a vector comprising the DNA, a transformant transformed with the vector, and a process for producing the phospholipase Apolypeptide. The present invention also relates to a method of utilizing the polypeptide, e.g., a method of screening for a compound having agonist or antagonist activity by using the polypeptide or an antibody to the polypeptide, and a pharmaceutical comprising the polypeptide or an antibody to the polypeptide. The present invention further relates to a polypeptide inhibiting the phospholipase Aactivity of a phospholipase Apolypeptide (hereinafter referred to as inhibitor polypeptide), DNA encoding the inhibitor polypeptide, a vector comprising the DNA encoding the inhibitor polypeptide, a transformant transformed with the vector, a pharmaceutical comprising the inhibitor polypeptide, and a process for producing the inhibitor polypeptide.


Find Patent Forward Citations

Loading…